Our Network

Our Network

Pharm Asia Drug plan focuses on expanding the manufacturing facilities and capacity for non-sterile pharmaceutical products as per WHO-cGMP norms. This will done by increasing Solid doses capabilities and liquid doses manufacturing capacities.. The expansion of the plant will add a new manufacturing suit including modern manufacturing and utility facility of cylo system for solid doses and this provide controlled/safe environment for handling materials and this will done by increasing the capabilities of manufacturing process. Our expansion towards the formulation of solid doses and liquid doses



img
img